Trends in the Prevalence of Fetal Macrosomia in the United States, 2004 to 2022

 SFX Search Buy Article Permissions and Reprints Abstract Objective

Globally, the prevalence of macrosomia varies widely, and the trends in macrosomia prevalence are controversial. We aim to analyze temporal changes in fetal macrosomia prevalence from 2004 to 2022.

Study Design

This study included 72,879,544 singleton deliveries from the U.S. National Vital Statistics System Natality Files. We used Joinpoint regression to assess annual trends in fetal macrosomia (birth weight: 4,000 g), further classified into Grade 1 (4,000-4,499 g), Grade 2 (4,500-4,999 g), and Grade 3 (5,000 g).

Results

The overall prevalence of fetal macrosomia declined overall from 8.85% (95% CIs: 8.83, 8.88) in 2004 to 7.42% (95% CIs: 7.40, 7.45) in 2022, representing an average annual relative decrease of 0.89% (95% CIs: -1.17%, -0.61%). The temporal trend was nonlinear: a sharp decrease from 2004–2007 (APC: -3.63; 95% CIs: -4.92, -2.32), a modest increase during 2007–2015 (APC: 0.79; 95% CIs: 0.41, 1.16), and a steady decline from 2015–2022 (APC: -1.59; 95% CIs: -1.98, -1.20). Subgroup analyses revealed consistent declines, with more pronounced reductions among women aged > 30 years, those with a college education, primiparous women, and Asian/Pacific Islander mothers. When stratified by severity, the prevalence of Grade 1 macrosomia decreased from 7.53% to 6.42% (AAPC: -0.80; 95% CIs: -1.06, -0.53), Grade 2 decreased from 1.13% to 0.84% (AAPC:-1.50; 95% CIs: -1.94, -1.06), and Grade 3 from 0.20% to 0.16% (AAPC: -0.85; 95% CIs: -1.42, -0.27).

Conclusion

The prevalence of fetal macrosomia has varied over time, showing an overall downward trend over the past 20 years, with two periods of rapid decline (2004–2007 and 2015–2022) and one period of moderate increase (2007–2015). The changes observed were significant for Grade 1 and Grade 2 macrosomia, while Grade 3 macrosomia also showed a downward trend, but without distinct segment slopes.

Key Points

The overall prevalence of fetal macrosomia in the United States declined from 8.85% in 2004 to 7.42% in 2022, with a non-linear trend marked by two periods of decline and one of moderate increase.

The trend was more pronounced among women aged >30 years, with college education, primiparous women, and Asian/Pacific Islander mothers.

Severity-stratified analyses revealed significant declines in Grade 1 and Grade 2, while Grade 3 demonstrated a modest decrease without distinct Joinpoint segments.

Keywords fetal macrosomia - trend - macrosomia subtypes - NVSS Data Availability Statement

Y.Z. had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Data sharing will be available from Y.Z. upon a reasonable request.


Contributors' Statement

G.D. and Y.Z. conceived this study. G.D., P.H., and C.S. drafted the manuscript. Y.Z. supervised the work and, together with A.V., conducted the literature review, revised the data, and critically reviewed the manuscript text for important intellectual content prior to publication.



‡ These authors contributed equally to this work.

Publication History

Received: 01 April 2025

Accepted: 05 September 2025

Article published online:
16 September 2025

© 2025. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

Comments (0)

No login
gif